FDA Expands Treatment Approval for Certain Hodgkin’s Lymphoma Patients
The FDA has just approved brentuximab vedotin to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma in combination with chemotherapy, an approval that “represents an improvement in […]